We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TENX market cap is 15.92M. The company's latest EPS is USD -2.2620 and P/E is -2.15.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.24M | -2.12M | -3.34M | -3.91M | -3.67M |
Net Income | -1.11M | -1.97M | -3.23M | -3.8M | -3.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.56M | -9.87M | -32.73M | -11.05M | -8.23M |
Net Income | -8.39M | -9.85M | -32.47M | -11.05M | -7.71M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.05M | 11.89M | 11.69M | 14.46M | 10.62M |
Total Liabilities | 823k | 602k | 3.59M | 2.03M | 1.74M |
Total Equity | 13.22M | 11.29M | 8.1M | 12.43M | 8.88M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.37M | 50M | 5.99M | 3.41M | 11.69M |
Total Liabilities | 2.59M | 0 | 1.75M | 1.91M | 3.59M |
Total Equity | 3.77M | 50M | 4.25M | 1.49M | 8.1M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.65M | -4.73M | -5.9M | -5.17M | -8.2M |
Investing | 3k | 3k | 3k | N/A | N/A |
Financing | 13.92M | 13.74M | 13.57M | 7.92M | 7.79M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.56M | -9.27M | -10.86M | -12.01M | -5.9M |
Investing | -2k | 20k | 452k | -2k | 3k |
Financing | 97k | 10.6M | 9.74M | 8.56M | 13.57M |
Market Cap | 15.92M |
Price to Earnings Ratio | -2.15 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.7 |
Price to Book Ratio | 2.05 |
Dividend Yield | - |
Shares Outstanding | 3.41M |
Average Volume (1 week) | 97.75k |
Average Volume (1 Month) | 95.43k |
52 Week Change | -83.78% |
52 Week High | 33.44 |
52 Week Low | 2.77 |
Spread (Intraday) | 0.6 (11.32%) |
Company Name | Tenax Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.tenaxthera.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions